On September 30, 2020 Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, reported that management will present at the following upcoming virtual investor conferences in October (Press release, Altimmune, SEP 30, 2020, View Source [SID1234567829]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright 4th Annual NASH Investor Conference
Monday, October 5, 2020 – 3:30 pm ET
Guggenheim Securities’ 1st Annual Vaccines & Infectious Diseases Day
Monday, October 5, 2020 – 4:45 pm ET
The H.C. Wainwright presentation will be webcast and can be accessed by visiting the investor relations section of the company’s website at www.altimmune.com under Events/Presentations.